Suchergebnisse - (Person:"Wang, Yeming")

PubPharm (182)

91

6-month consequences of COVID-19 in patients discharged from hospital : a cohort study

enthalten in: Lancet (London, England) | 2021

von Huang, C. | Huang, L. | Wang, Y. | +29

CommentIn: Lancet. 2021 Jan 16;397(10270):173-175. - PMID 33428868

92

Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Liu, Z. | Li, X. | Fan, G. | +15

93

Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19 : A Retrospective Cohort Study

enthalten in: Frontiers in immunology | 2021

von Wang, G. | Wang, Q. | Wang, Y. | +14

94

The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19 : A Living Systematic Review and Meta-Analysis

enthalten in: Frontiers in medicine | 2021

von Zhang, X. | Shang, L. | Fan, G. | +5

CommentIn: Dig Liver Dis. 2022 Nov;54(11):1598-1599. - PMID 36137935

95

P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF

enthalten in: Europäisches Patentamt | 2020

von ZHAO YANPING | WANG HONGJUN | WANG YEMING | +2

96

High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients

enthalten in: Emerging microbes & infections | 2020

von Li, H. | Ren, L. | Zhang, L. | +15

97

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza

enthalten in: EBioMedicine | 2020

von Wang, Y. | Zhong, W. | Salam, A. | +29

98

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak : a retrospective analysis

enthalten in: Frontiers of medicine | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

99

Endpoints for randomized controlled clinical trials for COVID-19 treatments

enthalten in: Clinical trials (London, England) | 2020

von Dodd, L. | Follmann, D. | Wang, J. | +12

CommentIn: Clin Trials. 2021 Apr;18(2):263-264. - PMID 33322940

100

Remdesivir and COVID-19 - Authors' reply

enthalten in: Lancet (London, England) | 2020

von Wang, Y. | Gu, X. | Xu, J. | +2

CommentOn: Lancet. 2020 Oct 3;396(10256):952. - PMID 33010830